Huang Michael F.
CIK 0002019992
Sr. VP of Clinical Development
Filings
7
Latest May 18, 2026
Issuers covered
1
Showing
7 of 7
Page 1
Track record
12 of 12 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 12 | 0% | -25.8% | -9.3% | -9.3% | -75.5% |
| 90 days | 9 | 0% | -27.3% | -27.3% | -27.3% | -27.3% |
| 180 days | 9 | 100% | +15.6% | +15.6% | +15.6% | +15.6% |
| 365 days | 9 | 100% | +55.4% | +55.4% | +55.4% | +55.4% |
Issuers
Companies where Huang Michael F. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 7 | May 18, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|